ACTIVE MYOCARDIAL DAMAGE IN HYPERTHYROIDISM - A CONCURRENT MECHANISM OF HEART-FAILURE REVERSED BY TREATMENT

被引:14
|
作者
MARTI, V [1 ]
BALLESTER, M [1 ]
OBRADOR, D [1 ]
MOYA, C [1 ]
CARRIO, I [1 ]
PONSLLADO, G [1 ]
机构
[1] HOSP SANTA CRUZ & SAN PABLO,NUCL MED UNIT,E-08025 BARCELONA,SPAIN
关键词
HYPERTHYROIDISM; MYOCARDIAL DAMAGE; MONOCLONAL ANTIMYOSIN ANTIBODIES; HEART FAILURE;
D O I
10.1093/oxfordjournals.eurheartj.a061014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient with hyperthyroidism, heart failure, and depressed ejection fraction, in whom myocardial damage was evidenced by In-111-labelled monoclonal antimyosin antibodies, is presented. Both myocardial damage and left ventricular dysfunction disappeared after antithyroid therapy. This suggests that, in addition to volume overload, heart failure in hyperthyroidism could be also due to the presence of potentially reversible concurrent myocardial damage.
引用
收藏
页码:1014 / 1016
页数:3
相关论文
共 50 条
  • [21] ARRHYTHMIAS IN CHRONIC HEART-FAILURE - PROGNOSTIC-SIGNIFICANCE AND TREATMENT
    KOENIG, A
    CHAUVIN, M
    THEVENIN, D
    BRECHENMACHER, C
    PRESSE MEDICALE, 1991, 20 (20): : 950 - 955
  • [22] IMPROVEMENT OF SEVERE HEART-FAILURE WITH CORTICOSTEROID-THERAPY IN A PATIENT WITH MYOCARDIAL SARCOIDOSIS
    SHIOTANI, H
    MIYAZAKI, T
    MATSUNAGA, K
    KADO, T
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1991, 55 (04): : 393 - 396
  • [23] Treatment strategies for myocardial recovery in heart failure topical collection on heart failure
    Lenneman A.J.
    Birks E.J.
    Current Treatment Options in Cardiovascular Medicine, 2014, 16 (3)
  • [24] IS TUMOR-NECROSIS-FACTOR AN IMPORTANT NEUROHORMONAL MECHANISM IN CHRONIC HEART-FAILURE
    PACKER, M
    CIRCULATION, 1995, 92 (06) : 1379 - 1382
  • [25] Hypothyroidism-induced myocardial damage and heart failure: an overlooked entity
    Shuvya, Mony
    Shifman, Oshrat E. Tayer
    Nusair, Samir
    Pappo, Orit
    Lotan, Chaim
    CARDIOVASCULAR PATHOLOGY, 2009, 18 (03) : 183 - 186
  • [26] INCREASED PLASMA ENDOTHELIN CONCENTRATIONS IN PATIENTS WITH ACUTE HEART-FAILURE AFTER MYOCARDIAL-INFARCTION
    NAKAMURA, M
    ARAKAWA, N
    YOSHIDA, H
    FUNAKOSHI, T
    CHIBA, M
    ABE, Y
    MAKITA, S
    AOKI, H
    HIRAMORI, K
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1993, 57 (05): : 371 - 378
  • [27] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE TREATMENT OF CLINICAL HEART-FAILURE
    POULEUR, H
    BASIC RESEARCH IN CARDIOLOGY, 1993, 88 : 203 - 209
  • [28] THEORETICAL BASIS FOR THE USE OF ANGIOTENSIN-II ANTAGONISTS IN THE TREATMENT OF HEART-FAILURE
    RUSH, JE
    RAJFER, SI
    JOURNAL OF HYPERTENSION, 1993, 11 : S69 - S71
  • [29] ENALAPRIL AS INITIAL AND SOLE TREATMENT IN SEVERE CHRONIC HEART-FAILURE WITH SODIUM RETENTION
    ANAND, IS
    KALRA, GS
    FERRARI, R
    WAHI, PL
    HARRIS, PC
    POOLEWILSON, PA
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1990, 28 (03) : 341 - 346
  • [30] Thoracic Epidural Anesthesia Reversed Myocardial Fibrosis in Patients With Heart Failure Caused by Dilated Cardiomyopathy
    Ma, Dan
    Liu, Lei
    Zhao, Hongwei
    Zhang, Ruiying
    Yun, Fengxiang
    Li, Lulu
    Wang, Yang
    Qu, Renhai
    Liu, Pengfei
    Liu, Fengqi
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2017, 31 (05) : 1672 - 1675